These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Stereoselective functionalisation of cis- and trans-2-ferrocenyl-3-pivaloyl-4-alkyl-1,3-oxazolidin-5-ones: asymmetric synthesis of (R)- and (S)-2-alkyl-2-aminopent-4-enoic acids and (2R,3S)-2-amino-2-methyl-3-hydroxy-3-phenylpropanoic acid.
    Author: Alonso F, Davies SG, Elend AS, Leech MA, Roberts PM, Smith AD, Thomson JE.
    Journal: Org Biomol Chem; 2009 Feb 07; 7(3):527-36. PubMed ID: 19156319.
    Abstract:
    Treatment of a range of cis- and trans-2-ferrocenyl-3-pivaloyl-4-alkyl-1,3-oxazolidin-5-ones with LDA followed by the addition of allyl bromide promotes highly stereoselective allylation (>98% de) at the 4-position of the oxazolidinone ring anti to the stereodirecting 2-ferrocenyl group. Hydrolysis of the resultant 4,4-disubstituted oxazolidinones (>98% de) yields enantiomeric (R)- and (S)-2-alkyl-2-aminopent-4-enoic acids in high ee. Furthermore, the aldol reaction of the lithium enolate of cis-2-ferrocenyl-3-pivaloyl-4-methyl-1,3-oxazolidin-5-one with benzaldehyde followed by in situ O-protection affords O-protected aldol products in >98% de, with hydrolysis affording (2R,3S)-2-amino-2-methyl-3-hydroxy-3-phenylpropanoic acid in >98% de.
    [Abstract] [Full Text] [Related] [New Search]